Results 21 to 30 of about 5,826 (213)

Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy

open access: yesThe World Journal of Men's Health, 2022
Patients with prostate cancer (PCa) on androgen-deprivation therapy (ADT) are at high risk of osteoporosis and fragility fractures. We aimed to provide some practical insights into the delivery of optimal bone health care for PCa patients, particularly
Enrique Casado   +5 more
doaj   +1 more source

Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats

open access: yeseJournal of Oral Maxillofacial Research, 2017
Objectives: Osteonecrosis of the jaws is a side effect associated with the use of bisphosphonates. Using histologic analysis, this study aimed to evaluate the influence of microbial colonies in the development of osteonecrosis in the jaws of rats ...
Felipe M. Silveira   +3 more
doaj   +1 more source

Renal secretion of diphosphonates in rats

open access: yesKidney International, 1975
Diphosphonates, characterized by a P--C--P bond, are relatively new experimental drugs used for the treatment of myositis ossificans, dental calculus, nephrolithiasis and Paget's disease. These compounds are not metabolized and the fraction which is not taken up by the skeleton is excreted unchanged in the urine.
Herbert Fleisch   +2 more
openaire   +3 more sources

Severe congestive heart failure in elderly patient with Paget’s disease

open access: yesGeriatric Care, 2017
Paget’s disease of bone is characterized by focal areas of increased bone turnover, affecting one or several bones throughout the skeleton. Paget’s disease is often asymptomatic, but can be associated with bone pain and other skeletal and non-skeletal ...
Lorenzo Palleschi, Eleonora Nunziata
doaj   +1 more source

PROFILAKTIKA NARUPENI OBMENA KAL'TsIYa I SISTEM EGO REGULYaTsII PRI DLITEL'NOY GIPOKINEZII S UChASTIEM ChELOVEKA

open access: yesОстеопороз и остеопатии, 2007
In conditions of 120-daily bedrest changes of a metabolism of the calcium, the functions of a bone directed on preservation at a necessary level of a bone material at the maximal economy level in these conditions were studied.
O I ORLOV
doaj   +1 more source

Rhenium Radioisotopes for Medicine, a Focus on Production and Applications

open access: yesMolecules, 2022
In recent decades, the use of alpha; pure beta; or beta/gamma emitters in oncology, endocrinology, and interventional cardiology rheumatology, has proved to be an important alternative to the most common therapeutic regimens. Among radionuclides used for
Licia Uccelli   +9 more
doaj   +1 more source

Diphosphonates in the treatment of osteoporosis

open access: yesCleveland Clinic Journal of Medicine, 1990
Etidronate disodium has been shown to increase bone density and decrease fracture rates, but it may have more important applications in the prevention of bone loss.
openaire   +3 more sources

Pamidronato dissódico (APD) no tratamento das metástases ósseas.

open access: yesActa Médica Portuguesa, 1993
Diphosphonates are potent inhibitors of bone resorption, they have been evaluated in several clinical trials for bone metastases. We performed a clinical study to evaluate the therapeutic effect of Disodium Pamidronate over pain and radiologic evolution ...
L Costa, C Moreira, E B da Costa
doaj   +1 more source

Bisphosphonate's and Intermittent Parathyroid Hormone's Effect on Human Spinal Fusion: A Systematic Review of the Literature [PDF]

open access: yesAsian Spine Journal, 2017
There has been a conscious effort to address osteoporosis in the aging population. As bisphosphonate and intermittent parathyroid hormone (PTH) therapy become more widely prescribed to treat osteoporosis, it is important to understand their effects on ...
Michael A. Stone   +9 more
doaj   +1 more source

CTHRC1 promotes bone metastasis in prostate cancer

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The mechanisms driving bone metastasis in prostate cancer are still unclear, and predicting markers have not yet been identified. Based on the biological characterization of prostate cancer cell lines and integrated data analysis of clinical samples, the authors identified CTHRC1 as a candidate gene regulating prostate cancer bone ...
Yuichiro Sawada   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy